Drugs / CP-481,715
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00141180 | Sep 2003 → Oct 2005 | allergic contact dermatitis | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CP-481,715 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00141180 ↗ |
| Action | Inhibit | “c-chemokine receptor-1 antagonist” NCT00141180 ↗ |